Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1973 1
1976 2
1977 3
1978 5
1979 4
1980 5
1981 9
1982 13
1983 12
1984 27
1985 32
1986 40
1987 49
1988 39
1989 38
1990 28
1991 37
1992 31
1993 33
1994 29
1995 27
1996 29
1997 31
1998 26
1999 27
2000 23
2001 24
2002 28
2003 25
2004 17
2005 24
2006 20
2007 22
2008 19
2009 13
2010 20
2011 22
2012 16
2013 15
2014 23
2015 16
2016 16
2017 26
2018 41
2019 45
2020 48
2021 59
2022 77
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

1,170 results
Results by year
Filters applied: . Clear all
Page 1
Nalbuphine.
Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, Vernier VG. Schmidt WK, et al. Drug Alcohol Depend. 1985 Feb;14(3-4):339-62. doi: 10.1016/0376-8716(85)90066-3. Drug Alcohol Depend. 1985. PMID: 2986929 Review.
Nalbuphine produces limited respiratory depression in animals and in man. ...Rather, due to nalbuphine's strong antagonist activity, analgesic-range doses of nalbuphine severely exacerbate the withdrawal syndrome in partly-withdrawn mice, monkeys and humans.
Nalbuphine produces limited respiratory depression in animals and in man. ...Rather, due to nalbuphine's strong antagonist act
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Candoni A, Lazzarotto D, Ferrara F, Curti A, Lussana F, Papayannidis C, Del Principe MI, Bonifacio M, Mosna F, Delia M, Minetto P, Gottardi M, Fracchiolla N, Mancini V, Forghieri F, Zappasodi P, Cerrano M, Vitale A, Audisio E, Trappolini S, Romani C, Defina M, Imbergamo S, Ciccone N, Santoro L, Cambò B, Iaccarino S, Dargenio M, Aprile L, Chiaretti S, Fanin R, Pizzolo G, Foà R. Candoni A, et al. Am J Hematol. 2020 Dec;95(12):1466-1472. doi: 10.1002/ajh.25957. Epub 2020 Aug 31. Am J Hematol. 2020. PMID: 32777149 Free article. Clinical Trial.
Nalbuphine #381.
Mathai F, Portugal F, Mehta Z, Davis M. Mathai F, et al. J Palliat Med. 2019 Nov;22(11):1471-1472. doi: 10.1089/jpm.2019.0482. J Palliat Med. 2019. PMID: 31661394 No abstract available.
Does nalbuphine have a niche in managing pain?
Davis MP, Fernandez C, Regel S, McPherson ML. Davis MP, et al. J Opioid Manag. 2018 Mar/Apr;14(2):143-151. doi: 10.5055/jom.2018.0441. J Opioid Manag. 2018. PMID: 29733100 Review.
Nalbuphine pharmacokinetics are moderately altered in renal failure. ...Nalbuphine, despite being a receptor antagonist produces a drug-liking effect and can be abused. ...
Nalbuphine pharmacokinetics are moderately altered in renal failure. ...Nalbuphine, despite being a receptor antagonist produc
[Nalbuphine in pediatric anesthesia].
Schultz-Machata AM, Becke K, Weiss M. Schultz-Machata AM, et al. Anaesthesist. 2014 Feb;63(2):135-43. doi: 10.1007/s00101-014-2293-z. Anaesthesist. 2014. PMID: 24504192 Review. German.
Efficient and safe pediatric perioperative pain therapy in the context of a multimodal pain therapy concept requires a slight to moderate opioid analgesic. Nalbuphine is a nearly ideal opioid for this purpose due to its unique pharmacological properties as a mu-receptor an …
Efficient and safe pediatric perioperative pain therapy in the context of a multimodal pain therapy concept requires a slight to moderate op …
Effects of nalbuphine on the cardiotoxicity of ropivacaine in rats.
Wang C, Sun S, Jiao J, Yu X, Huang S. Wang C, et al. Fundam Clin Pharmacol. 2022 Oct;36(5):811-817. doi: 10.1111/fcp.12778. Epub 2022 Apr 9. Fundam Clin Pharmacol. 2022. PMID: 35373856
When combined with nalbuphine, local anesthetics show a longer duration of nerve block without increasing complications. However, no evidence is available concerning the effect of nalbuphine on the cardiotoxicity of local anesthetics. The objective of this work is t …
When combined with nalbuphine, local anesthetics show a longer duration of nerve block without increasing complications. However, no …
[Pharmacology of nalbuphine].
Arnould JF, Pinaud M. Arnould JF, et al. Ann Fr Anesth Reanim. 1992;11(2):221-8. doi: 10.1016/S0750-7658(05)80018-8. Ann Fr Anesth Reanim. 1992. PMID: 1503299 Review. French. No abstract available.
Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice.
Narver HL. Narver HL. Lab Anim (NY). 2015 Mar;44(3):106-10. doi: 10.1038/laban.701. Lab Anim (NY). 2015. PMID: 25693108 Review.
The author reviews the characteristics of nalbuphine, analyzes studies of nalbuphine in mice and explores the potential use of nalbuphine to treat pain in research mice. In analgesiometric studies in mice, nalbuphine ameliorates both somatic and viscer …
The author reviews the characteristics of nalbuphine, analyzes studies of nalbuphine in mice and explores the potential use of …
Nalbuphine for Treatment of Opioid-induced Pruritus: A Systematic Review of Literature.
Jannuzzi RG. Jannuzzi RG. Clin J Pain. 2016 Jan;32(1):87-93. doi: 10.1097/AJP.0000000000000211. Clin J Pain. 2016. PMID: 26650717 Review.
There are several options available to treat opioid-induced pruritus, including nalbuphine. However, it is not known whether nalbuphine offers greater efficacy in treating pruritus without attenuation of analgesia and an increase in the incidence of adverse outcomes …
There are several options available to treat opioid-induced pruritus, including nalbuphine. However, it is not known whether nalbu
Effect of Preventive Analgesia with Nalbuphine and Dexmedetomidine in Endoscopic Sinus Surgery.
Yu P, Zhang J, Zou Y, Wang J. Yu P, et al. Pain Res Manag. 2022 May 31;2022:2344733. doi: 10.1155/2022/2344733. eCollection 2022. Pain Res Manag. 2022. PMID: 35685676 Free PMC article. Clinical Trial.
METHODS: 110 patients with deviation of the nasal septum were randomized into the nalbuphine group (group N), dexmedetomidine combined with nalbuphine group (group DN), and saline group (group C). Fifteen minutes before the induction of anesthesia, patients in group …
METHODS: 110 patients with deviation of the nasal septum were randomized into the nalbuphine group (group N), dexmedetomidine combine …
1,170 results